Synthetic dihydropacidamycin antibiotics: A modified spectrum of activity for the pacidamycin class

被引:27
作者
Boojamra, CG [1 ]
Lemoine, RC [1 ]
Blais, J [1 ]
Vernier, NG [1 ]
Stein, KA [1 ]
Magon, A [1 ]
Chamberland, S [1 ]
Hecker, SJ [1 ]
Lee, VJ [1 ]
机构
[1] Essential Therapeut Inc, Mountain View, CA 94043 USA
关键词
D O I
10.1016/S0960-894X(03)00682-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Dihydropacidamycins having an antibacterial spectrum modified from that of the natural product pacidamycins and mureidomycins have been synthesized. Synthetic dihydropacidamycins with noteworthy antibacterial activity against wild-type and resistant Escherichia coli have been identified (MIC = 4-8 mug/mL). Some dihydropacidamycins are shown to have activity against multi-resistant clinical strains of Mycobacterium tuberculosis. Compounds of this class are inhibitors of the cell wall biosynthetic enzyme, MraY. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3305 / 3309
页数:5
相关论文
共 33 条
[21]   NUCLEOSIDE ANTIBIOTICS - STRUCTURE, BIOLOGICAL-ACTIVITY, AND BIOSYNTHESIS [J].
ISONO, K .
JOURNAL OF ANTIBIOTICS, 1988, 41 (12) :1711-1739
[22]  
Jacoby GA, 1996, ANNU REV MED, V47, P169
[23]   PACIDAMYCINS, A NOVEL SERIES OF ANTIBIOTICS WITH ANTI-PSEUDOMONAS-AERUGINOSA ACTIVITY .1. TAXONOMY OF THE PRODUCING ORGANISM AND FERMENTATION [J].
KARWOWSKI, JP ;
JACKSON, M ;
THERIAULT, RJ ;
CHEN, RH ;
BARLOW, GJ ;
MAUS, ML .
JOURNAL OF ANTIBIOTICS, 1989, 42 (04) :506-511
[24]   Efflux pumps: Their role in antibacterial drug discovery [J].
Lomovskaya, O ;
Watkins, WJ .
CURRENT MEDICINAL CHEMISTRY, 2001, 8 (14) :1699-1711
[25]   Glycopeptide derivatives [J].
Malabarba, A ;
Ciabatti, R .
CURRENT MEDICINAL CHEMISTRY, 2001, 8 (14) :1759-1773
[26]  
*NCCLS, 1997, METHODS DILUTION ANT, V17
[27]   PREVENTION OF DRUG ACCESS TO BACTERIAL TARGETS - PERMEABILITY BARRIERS AND ACTIVE EFFLUX [J].
NIKAIDO, H .
SCIENCE, 1994, 264 (5157) :382-388
[28]   To gown or not to gown: The effect on acquisition of vancomycin-resistant enterococci [J].
Puzniak, LA ;
Leet, T ;
Mayfield, J ;
Kollef, M ;
Mundy, LM .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (01) :18-25
[29]   Inhibitors of efflux pumps in Pseudomonas aeruginosa potentiate the activity of the fluoroquinolone antibacterial levofloxacin [J].
Renau, TE ;
Léger, R ;
Flamme, EM ;
Sangalang, J ;
She, MW ;
Yen, R ;
Gannon, CL ;
Griffith, D ;
Chamberland, S ;
Lomovskaya, O ;
Hecker, SJ ;
Lee, VJ ;
Ohta, T ;
Nakayama, K .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (24) :4928-4931
[30]   Efflux pump inhibitors to address bacterial and fungal resistance [J].
Renau, TE ;
Lemoine, RC .
DRUGS OF THE FUTURE, 2001, 26 (12) :1171-1178